Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: an animal model of multiple risk factors.
The present study was designed to develop an animal model of multiple risk factors, including obesity, hypertension, non-insulin-dependent diabetes mellitus, and hyperlipidemia. Hypothalamic obesity was induced by neonatal monosodium glutamate (MSG) treatment in spontaneously hypertensive rats (SHR). Female newborn SHR were treated intraperitoneally with 2 or 4 mg/kg body weight of MSG for 5 days. Obesity developed in SHR treated with 4 mg/kg of MSG but not in SHR treated with 2 mg/kg of MSG. Obese SHR had impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia. However, the severity of hypertension was attenuated in obese SHR as compared with control SHR. The degree of obesity was closely related to the metabolic abnormalities, but inversely correlated with the blood pressure level. Macrovascular changes were investigated in obese SHR at 14 months of age. Intimal thickening was accelerated in the carotid artery of obese SHR as compared with that of nonobese SHR. Aortic contents of DNA and total cholesterol were significantly increased in obese SHR. SHR associated with MSG-induced obesity showed major manifestations of metabolic syndrome X. This animal model may be useful to study the clustering of risk factors for the development of macrovascular diseases.
Iwase
M
M
Second Department of Internal Medicine, Kyushu University, Fukuoka, Japan.
Yamamoto
M
M
Iino
K
K
Ichikawa
K
K
Shinohara
N
N
Yoshinari
M
M
Fujishima
M
M
D000818:Animals; D000831:Animals, Newborn; D001011:Aorta / Q000737:chemistry; D001161:Arteriosclerosis / Q000453:epidemiology / Q000473:pathology / Q000503:physiopathology*; D002339:Carotid Arteries / Q000473:pathology; D002784:Cholesterol / Q000032:analysis; D004247:DNA / Q000032:analysis; D003921:Diabetes Mellitus, Experimental / Q000453:epidemiology / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000503:physiopathology*; D004195:Disease Models, Animal; D005260:Female; D005503:Food Additives; D006442:Glycated Hemoglobin / Q000032:analysis; D006946:Hyperinsulinism / Q000453:epidemiology / Q000503:physiopathology; D006949:Hyperlipidemias / Q000453:epidemiology / Q000503:physiopathology; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology*; D015228:Hypertriglyceridemia / Q000453:epidemiology / Q000503:physiopathology; D009765:Obesity / Q000139:chemically induced / Q000453:epidemiology / Q000503:physiopathology*; D051381:Rats; D011918:Rats, Inbred SHR; D012307:Risk Factors; D012970:Sodium Glutamate; D017539:Tunica Intima / Q000473:pathology
D002784:Cholesterol; D004247:DNA; D005503:Food Additives; D006442:Glycated Hemoglobin; D012970:Sodium Glutamate